USPTO serial 79413826
Serial No. 79413826
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- FLETCHER, TRACY L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 79413826?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
J. Scott Evans
J. Scott Evans Stobbs214 W. Tremont AveSuite 303Charlotte, NC 28203Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic preparations for medical or veterinary purposes in the nature of peptide and polypeptide substrates; Therapeutic synthetic peptides and polypeptides for medical purposes, namely, therapeutic peptides and polypeptides used to target protein expression in diseased tissues for the treatment of cancer, autoimmune disorders, inflammation, neurological disorders, diabetes, obesity; Proteins arrays for medical diagnosis purposes; Biochemical and biological substances for medical diagnostics and analysis being diagnostic preparations for medical purposes; Pharmaceutical preparations for medical purposes, namely, pharmaceutical preparations that selectively target protein expression in diseased tissues for the treatment of cancer, autoimmune disorders, inflammation, neurological disorders, diabetes, obesity; Pharmaceutical preparations, namely, antivirals | ACTIVE | — |
| 042 | Scientific, pharmaceutical, medical, biological, biochemical and biotechnology research; Research in the field of diagnostic preparations; Biochemical and biotechnological engineering; Engineering services in the field of peptides, proteins, molecules, antibodies, polypeptides and polymers | ACTIVE | — |
| 045 | Licensing of intellectual property rights and legal services relating to the exploitation of intellectual property rights and of technology; Licensing of intellectual property rights in technology relating to discovery of peptides for therapeutic and non-therapeutic applications | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 22, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 22, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 22, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 22, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 22, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 15, 2026 | RDX3 | NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED | — |
| Jul 15, 2026 | RDX1 | ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED | — |
| Jul 15, 2026 | RRDX | ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED | — |
| Jul 14, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 14, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 14, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 18, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 1, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 31, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 22, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 22, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 22, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 21, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 21, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 21, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 15, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 29, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 29, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 12, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 11, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 6, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 5, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 5, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 2, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |